Business Context and Reporting Period
Company: Accendra Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 22, 2026
Primary Event: Launch of Exchange Offers and Consent Solicitations for outstanding senior notes.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, or liquidity metrics. It focuses exclusively on capital structure restructuring.
| Instrument | Details |
|---|---|
| Old Notes (Retired) | 4.500% Senior Notes due 2029 6.625% Senior Notes due 2030 |
| New Notes (Issued) | 9.000% Senior Secured First Lien Notes due 2032 9.750% Senior Secured Second Lien Notes due 2033 |
Material Changes
The Company is executing a debt exchange to replace existing unsecured senior notes with new secured notes carrying significantly higher interest rates:
- Interest Rate Increase: Coupon rates are increasing from 4.500% and 6.625% to 9.000% and 9.750%.
- Security Status: The new notes are secured (First and Second Lien), whereas the old notes were unsecured.
- Maturity Extension: Maturities are extended to 2032 and 2033.
Guidance, Outlook, and Risks
Management Commentary: The transaction is subject to conditions and may be amended or terminated at the Company's discretion. The filing includes standard forward-looking statements regarding the potential completion of the transaction.
Risks and Contingencies:
- Completion Risk: The Offers and Consent Solicitations may not be completed as contemplated or at all.
- Financial Impact: Failure to complete the transaction on favorable terms could materially adversely affect the Company's financial condition.
- Operational Distraction: Risks related to management attention being diverted from ongoing operations.
- Regulatory: New Notes are not registered under the Securities Act and cannot be sold in the U.S. without an exemption.
Investor Verification Checklist
- Verify the total principal amount of Old Notes outstanding eligible for exchange.
- Confirm the specific terms of the "new money" issuance required for the First Lien Notes.
- Review the attached Press Release (Exhibit 99.1) for detailed exchange ratios and consideration.
- Assess the impact of the increased interest expense (9.000% and 9.750%) on future cash flow requirements.
- Monitor subsequent filings for updates on the acceptance rate of the Exchange Offers.